SUSTITUTED ( HETEROARYLMETHYL ) THIOHYDANTOINS AS ANTICANCER DRUGS

Disclosed herein is a thiohydantoin compound of formula (I) wherein the variables are defined in the specification, a method for the preparation thereof involving the reaction of an isothiocyanate intermediate with a nitrile intermediate which is then hydrolysed to yield a compound of formula (I) an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KOHR, SILKE, HAENDLER, BERNARD, FAUS GIMENEZ, HORTENSIA, CLEVE, ARWED, LUCKING, ULRICH, IRLBACHER, HORST
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KOHR, SILKE
HAENDLER, BERNARD
FAUS GIMENEZ, HORTENSIA
CLEVE, ARWED
LUCKING, ULRICH
IRLBACHER, HORST
description Disclosed herein is a thiohydantoin compound of formula (I) wherein the variables are defined in the specification, a method for the preparation thereof involving the reaction of an isothiocyanate intermediate with a nitrile intermediate which is then hydrolysed to yield a compound of formula (I) and optionally reacted with the corresponding solvents and/or bases or acids to the solvates, salts and/or solvates of the salts thereof, for use in the treatment of a prostate cancer. Exemplary compounds include: 4-(3-{ [6-(1H-imidazol-1-yl)pyridin-3-yl]methyl} -4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile; 4-(4,4-dimethyl-3-{ [ 6-(2-methylmorpholin-4-yl)pyridin-3 -yl] methyl} -5-oxo-2-thioxoimidazolidin-l-yl)-2-(trifluoromethyl)benzonitrile; and 4-(3-{ [6-(2-methoxyethoxy)pyridin-3 -yl]methyl} -4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ598643A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ598643A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ598643A3</originalsourceid><addsrcrecordid>eNrjZHAKDg0O8QwJDXF1UdBQ8HANcQ3ydwyK9PF1DfGI9FHQVAjx8PT3iHRx9Avx9_QLVnAEIr8QT2dHP2fXIAWXoFD3YB4G1rTEnOJUXijNzSDn5hri7KGbWpAfn1pckJicmpdaEu8XZWppYWZi7GhMUAEAMOMqfg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUSTITUTED ( HETEROARYLMETHYL ) THIOHYDANTOINS AS ANTICANCER DRUGS</title><source>esp@cenet</source><creator>KOHR, SILKE ; HAENDLER, BERNARD ; FAUS GIMENEZ, HORTENSIA ; CLEVE, ARWED ; LUCKING, ULRICH ; IRLBACHER, HORST</creator><creatorcontrib>KOHR, SILKE ; HAENDLER, BERNARD ; FAUS GIMENEZ, HORTENSIA ; CLEVE, ARWED ; LUCKING, ULRICH ; IRLBACHER, HORST</creatorcontrib><description>Disclosed herein is a thiohydantoin compound of formula (I) wherein the variables are defined in the specification, a method for the preparation thereof involving the reaction of an isothiocyanate intermediate with a nitrile intermediate which is then hydrolysed to yield a compound of formula (I) and optionally reacted with the corresponding solvents and/or bases or acids to the solvates, salts and/or solvates of the salts thereof, for use in the treatment of a prostate cancer. Exemplary compounds include: 4-(3-{ [6-(1H-imidazol-1-yl)pyridin-3-yl]methyl} -4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile; 4-(4,4-dimethyl-3-{ [ 6-(2-methylmorpholin-4-yl)pyridin-3 -yl] methyl} -5-oxo-2-thioxoimidazolidin-l-yl)-2-(trifluoromethyl)benzonitrile; and 4-(3-{ [6-(2-methoxyethoxy)pyridin-3 -yl]methyl} -4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20131025&amp;DB=EPODOC&amp;CC=NZ&amp;NR=598643A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20131025&amp;DB=EPODOC&amp;CC=NZ&amp;NR=598643A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KOHR, SILKE</creatorcontrib><creatorcontrib>HAENDLER, BERNARD</creatorcontrib><creatorcontrib>FAUS GIMENEZ, HORTENSIA</creatorcontrib><creatorcontrib>CLEVE, ARWED</creatorcontrib><creatorcontrib>LUCKING, ULRICH</creatorcontrib><creatorcontrib>IRLBACHER, HORST</creatorcontrib><title>SUSTITUTED ( HETEROARYLMETHYL ) THIOHYDANTOINS AS ANTICANCER DRUGS</title><description>Disclosed herein is a thiohydantoin compound of formula (I) wherein the variables are defined in the specification, a method for the preparation thereof involving the reaction of an isothiocyanate intermediate with a nitrile intermediate which is then hydrolysed to yield a compound of formula (I) and optionally reacted with the corresponding solvents and/or bases or acids to the solvates, salts and/or solvates of the salts thereof, for use in the treatment of a prostate cancer. Exemplary compounds include: 4-(3-{ [6-(1H-imidazol-1-yl)pyridin-3-yl]methyl} -4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile; 4-(4,4-dimethyl-3-{ [ 6-(2-methylmorpholin-4-yl)pyridin-3 -yl] methyl} -5-oxo-2-thioxoimidazolidin-l-yl)-2-(trifluoromethyl)benzonitrile; and 4-(3-{ [6-(2-methoxyethoxy)pyridin-3 -yl]methyl} -4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHAKDg0O8QwJDXF1UdBQ8HANcQ3ydwyK9PF1DfGI9FHQVAjx8PT3iHRx9Avx9_QLVnAEIr8QT2dHP2fXIAWXoFD3YB4G1rTEnOJUXijNzSDn5hri7KGbWpAfn1pckJicmpdaEu8XZWppYWZi7GhMUAEAMOMqfg</recordid><startdate>20131025</startdate><enddate>20131025</enddate><creator>KOHR, SILKE</creator><creator>HAENDLER, BERNARD</creator><creator>FAUS GIMENEZ, HORTENSIA</creator><creator>CLEVE, ARWED</creator><creator>LUCKING, ULRICH</creator><creator>IRLBACHER, HORST</creator><scope>EVB</scope></search><sort><creationdate>20131025</creationdate><title>SUSTITUTED ( HETEROARYLMETHYL ) THIOHYDANTOINS AS ANTICANCER DRUGS</title><author>KOHR, SILKE ; HAENDLER, BERNARD ; FAUS GIMENEZ, HORTENSIA ; CLEVE, ARWED ; LUCKING, ULRICH ; IRLBACHER, HORST</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ598643A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KOHR, SILKE</creatorcontrib><creatorcontrib>HAENDLER, BERNARD</creatorcontrib><creatorcontrib>FAUS GIMENEZ, HORTENSIA</creatorcontrib><creatorcontrib>CLEVE, ARWED</creatorcontrib><creatorcontrib>LUCKING, ULRICH</creatorcontrib><creatorcontrib>IRLBACHER, HORST</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KOHR, SILKE</au><au>HAENDLER, BERNARD</au><au>FAUS GIMENEZ, HORTENSIA</au><au>CLEVE, ARWED</au><au>LUCKING, ULRICH</au><au>IRLBACHER, HORST</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUSTITUTED ( HETEROARYLMETHYL ) THIOHYDANTOINS AS ANTICANCER DRUGS</title><date>2013-10-25</date><risdate>2013</risdate><abstract>Disclosed herein is a thiohydantoin compound of formula (I) wherein the variables are defined in the specification, a method for the preparation thereof involving the reaction of an isothiocyanate intermediate with a nitrile intermediate which is then hydrolysed to yield a compound of formula (I) and optionally reacted with the corresponding solvents and/or bases or acids to the solvates, salts and/or solvates of the salts thereof, for use in the treatment of a prostate cancer. Exemplary compounds include: 4-(3-{ [6-(1H-imidazol-1-yl)pyridin-3-yl]methyl} -4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile; 4-(4,4-dimethyl-3-{ [ 6-(2-methylmorpholin-4-yl)pyridin-3 -yl] methyl} -5-oxo-2-thioxoimidazolidin-l-yl)-2-(trifluoromethyl)benzonitrile; and 4-(3-{ [6-(2-methoxyethoxy)pyridin-3 -yl]methyl} -4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_NZ598643A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title SUSTITUTED ( HETEROARYLMETHYL ) THIOHYDANTOINS AS ANTICANCER DRUGS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T06%3A21%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KOHR,%20SILKE&rft.date=2013-10-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ598643A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true